スペラネクサス Company Profile

We will respond to our customers' more detailed requests regarding pharmaceutical raw materials in a one-stop manner.

Speranexus was established in June 2021 through the integration of the fine chemical businesses of Iwaki Co., Ltd. and Iwaki Pharmaceutical Co., Ltd. By maximizing the advantages of both trading and manufacturing functions, we have become capable of responding to the more detailed requests of our customers involved in pharmaceutical raw materials in a one-stop manner. [Trading Function] We procure pharmaceutical raw materials from around the world by leveraging our overseas network. Additionally, we conduct domestic management operations for imported raw materials, and we have our own warehouse where we also perform quality assurance testing in our in-house laboratory. To meet demands from upstream to downstream, we are expanding our handling of pharmaceutical intermediates and starting materials, and we have various supply achievements regarding pharmaceutical raw materials. [Manufacturing Function] Based on the diverse and advanced synthetic technologies accumulated over many years, we manufacture and sell raw materials and chemical products.